Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00129428 · ClinicalTrials.gov registry record · Phase 1
Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix
A Phase 1 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 1
- Development phase
- 33
- Enrollment target
NCT00129428 is a Phase 1 study that has completed, run by University of Michigan. The registered enrollment target is 33 participants.
The verdict
NCT00129428, a Phase 1 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 33 participants
- Enrollment target
Study Summary
This research study will evaluate the effectiveness of high dose UVB light therapy in the treatment of keloid (or hypertrophic scar), scleroderma, acne keloidalis nuchae, old burn scars, granuloma annulare or related conditions.
Interventions
- PROCEDURE UVB Irradiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2002-08 |
| Est. Completion | 2009-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00129428
The ClinicalTrials.gov registry entry for NCT00129428 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which UVB Irradiation is the first listed.
NCT00129428 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00129428 about?
NCT00129428 is a clinical study titled "Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix". This research study will evaluate the effectiveness of high dose UVB light therapy in the treatment of keloid (or hypertrophic scar), scleroderma, acne keloidalis nuchae, old burn scars, granuloma annulare or related conditions.
What is the current status of trial NCT00129428?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 33 participants. The study started on 2002-08. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00129428?
The interventions under investigation include: UVB Irradiation (PROCEDURE).
Who is sponsoring clinical trial NCT00129428?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.